Production (Stage)
Appili Therapeutics Inc.
APLIF
$0.0137
$0.001916.10%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.92M | -2.90M | -2.63M | -2.82M | -2.81M |
| Total Depreciation and Amortization | 9.70K | 10.00K | 9.60K | 10.10K | 10.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.66M | 2.12M | 1.52M | 1.19M | 476.20K |
| Change in Net Operating Assets | -143.00K | 319.80K | 1.16M | 1.20M | 489.10K |
| Cash from Operations | 608.00K | -451.30K | 50.80K | -425.90K | -1.84M |
| Capital Expenditure | -1.70K | -1.70K | -1.20K | 0.00 | -22.10K |
| Sale of Property, Plant, and Equipment | -- | 500.00 | 500.00 | 500.00 | 500.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.70K | -1.20K | -700.00 | 500.00 | -21.60K |
| Total Debt Issued | 400.00K | 400.00K | 400.00K | 550.00K | 300.00K |
| Total Debt Repaid | -141.90K | -122.30K | -122.80K | -116.00K | -96.40K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -64.50K | -74.20K | -79.00K | -81.20K | -81.60K |
| Cash from Financing | 144.20K | 148.70K | 144.00K | 258.80K | 91.60K |
| Foreign Exchange rate Adjustments | 51.40K | 2.60K | -800.00 | -200.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 801.80K | -301.40K | 193.10K | -166.90K | -1.77M |